Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Human Olfactory Mucosa Stem Cells Delivery Using a Collagen Hydrogel: As a Potential Candidate for Bone Tissue Engineering Publisher



Simorgh S1, 2 ; Milan PB1, 2 ; Saadatmand M3 ; Bagher Z2, 4 ; Gholipourmalekabadi M1, 2 ; Alizadeh R4 ; Hivechi A1 ; Arabpour Z5, 6 ; Hamidi M7 ; Delattre C8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, 1591639675, Iran
  2. 2. Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, 1591639675, Iran
  3. 3. Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, 11155�9465, Iran
  4. 4. ENT and Head and Neck Research Center and Department, Hazrat Rasoul Akram Hospital, The Five Senses Health Institute, Iran University of Medical Sciences, Tehran, 1445613111, Iran
  5. 5. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran
  6. 6. Iranian Tissue Bank & Research Center, Tehran University of Medical Sciences, Teheran, 1419733141, Iran
  7. 7. Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, 4477166595, Iran
  8. 8. Universite Clermont Auvergne, Clermont Auvergne INP, CNRS, Institut Pascal, Clermont�Ferrand, F�63000, France
  9. 9. Institut Universitaire de France (IUF), 1 rue Descartes, Paris, 75005, France

Source: Materials Published:2021


Abstract

For bone tissue engineering, stem cell‐based therapy has become a promising option. Re-cently, cell transplantation supported by polymeric carriers has been increasingly evaluated. Herein, we encapsulated human olfactory ectomesenchymal stem cells (OE‐MSC) in the collagen hydrogel system, and their osteogenic potential was assessed in vitro and in vivo conditions. Col-lagen type I was composed of four different concentrations of (4 mg/mL, 5 mg/mL, 6 mg/mL, 7 mg/mL). SDS‐Page, FTIR, rheologic test, resazurin assay, live/dead assay, and SEM were used to characterize collagen hydrogels. OE‐MSCs encapsulated in the optimum concentration of collagen hydrogel and transplanted in rat calvarial defects. The tissue samples were harvested after 4‐ and 8‐weeks post‐transplantation and assessed by optical imaging, micro CT, and H&E staining meth-ods. The highest porosity and biocompatibility were confirmed in all scaffolds. The collagen hydro-gel with 7 mg/mL concentration was presented as optimal mechanical properties close to the naive bone. Furthermore, the same concentration illustrated high osteogenic differentiation confirmed by real‐time PCR and alizarin red S methods. Bone healing has significantly occurred in defects treated with OE‐MSCs encapsulated hydrogels in vivo. As a result, OE‐MSCs with suitable carriers could be used as an appropriate cell source to address clinical bone complications. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Related Docs
Experts (# of related papers)